"prostate tumor progression" trang 13 - tải miễn phí từ tailieunhanh
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer

Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
20    88    1
Quality indicators of clinical cancer care for prostate cancer: A population-based study in southern Switzerland

Quality indicators of clinical cancer care for prostate cancer: A population-based study in southern Switzerland
16    95    1
LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression

LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression
13    30    1
Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: An observational casecontrol study

Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: An observational casecontrol study
12    53    1
Race and BMI modify associations of calcium and vitamin D intake with prostate cancer

Race and BMI modify associations of calcium and vitamin D intake with prostate cancer
14    72    1
Testis specific Y-like 5: Gene expression, methylation and implications for drug sensitivity in prostate carcinoma

Testis specific Y-like 5: Gene expression, methylation and implications for drug sensitivity in prostate carcinoma
13    36    1
Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer

Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer
14    64    1
Cyproterone acetate enhances TRAILinduced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5

Cyproterone acetate enhances TRAILinduced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5
11    57    1
The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice

The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
12    51    1
Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: A meta-analysis

Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: A meta-analysis
9    46    1
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
10    49    1
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
10    53    1
Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis

Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis
13    72    1
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
12    60    1
Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: A study protocol

Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: A study protocol
12    61    1
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: Results from a multicenter biopsy study

Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: Results from a multicenter biopsy study
6    42    1
Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer

Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
6    50    1
Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer

Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
9    69    1
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer
11    82    1
A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer

A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer
6    38    1